Will the 40-gene expression classifier predict responders to EGFR targeted chemotherapy for the invasive bladder

Jayoung Kim1, Wun-Jae Kim1

  • 11 Department of Surgery, Harvard Medical School, Boston, MA 02114, USA ; 2 Division of Cancer Biology and Therapeutics, Department of Surgery and Biomedical Sciences, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA ; 3 Department of Medicine, University of California, Los Angeles, CA 90095, USA ; 4 Department of Urology, Chungbuk National University College of Medicine, Cheongju 361-763, Republic of Korea.

Abstract

No abstract available in PubMed .